B. Strobl

2.4k total citations
24 papers, 808 citations indexed

About

B. Strobl is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, B. Strobl has authored 24 papers receiving a total of 808 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 10 papers in Cancer Research and 6 papers in Pathology and Forensic Medicine. Recurrent topics in B. Strobl's work include Breast Cancer Treatment Studies (10 papers), Breast Lesions and Carcinomas (5 papers) and Cancer Cells and Metastasis (4 papers). B. Strobl is often cited by papers focused on Breast Cancer Treatment Studies (10 papers), Breast Lesions and Carcinomas (5 papers) and Cancer Cells and Metastasis (4 papers). B. Strobl collaborates with scholars based in Germany and Austria. B. Strobl's co-authors include Wolfgang Janni, Brigitte Rack, D. Rjosk, Christian Schindlbeck, Harald Sommer, H. Sommer, Kristin Härtl, Klaus Friese, R Kästner and M. Stauber and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Annals of Oncology.

In The Last Decade

B. Strobl

23 papers receiving 770 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Strobl Germany 12 589 273 186 104 103 24 808
Philip D. Poorvu United States 15 345 0.6× 179 0.7× 133 0.7× 102 1.0× 104 1.0× 44 718
Alan C. Winfield United States 14 272 0.5× 262 1.0× 82 0.4× 149 1.4× 65 0.6× 32 915
J M Howat United Kingdom 13 280 0.5× 207 0.8× 89 0.5× 148 1.4× 75 0.7× 37 751
Margriet van der Heiden‐van der Loo Netherlands 20 383 0.7× 472 1.7× 163 0.9× 217 2.1× 299 2.9× 67 1.1k
Michael Method United States 18 667 1.1× 121 0.4× 210 1.1× 117 1.1× 55 0.5× 73 1.3k
İbrahim Vedat Bayoğlu Türkiye 17 606 1.0× 147 0.5× 268 1.4× 147 1.4× 32 0.3× 75 843
Mustafa Oktay Tarhan Türkiye 18 612 1.0× 180 0.7× 228 1.2× 108 1.0× 29 0.3× 63 867
Anne Schlesinger‐Raab Germany 17 1.0k 1.7× 246 0.9× 310 1.7× 528 5.1× 94 0.9× 32 1.4k
Bert N. van Geel Netherlands 14 419 0.7× 173 0.6× 175 0.9× 83 0.8× 73 0.7× 17 786
Magali Verheecke Belgium 12 495 0.8× 183 0.7× 83 0.4× 67 0.6× 303 2.9× 24 792

Countries citing papers authored by B. Strobl

Since Specialization
Citations

This map shows the geographic impact of B. Strobl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Strobl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Strobl more than expected).

Fields of papers citing papers by B. Strobl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Strobl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Strobl. The network helps show where B. Strobl may publish in the future.

Co-authorship network of co-authors of B. Strobl

This figure shows the co-authorship network connecting the top 25 collaborators of B. Strobl. A scholar is included among the top collaborators of B. Strobl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Strobl. B. Strobl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rack, Brigitte, Julia Jückstöck, A. Schoberth, et al.. (2010). Effect of zoledronate on persisting isolated tumour cells in patients with early breast cancer.. PubMed. 30(5). 1807–13. 99 indexed citations
2.
Rack, Brigitte, Christian Schindlbeck, B. Strobl, et al.. (2008). Zoledronsäure bei persistierenden isolierten Tumorzellen im Knochenmark bei Mammakarzinom. DMW - Deutsche Medizinische Wochenschrift. 133(7). 285–289. 21 indexed citations
3.
Jueckstock, J, Ioannis Mylonas, B. Strobl, et al.. (2007). Paravasation with Cyclophosphamide – Case Report of Tissue Necrosis in a Patient with Primary Breast Cancer. Oncology Research and Treatment. 30(8-9). 452–454. 7 indexed citations
4.
Janni, Wolfgang, Brigitte Rack, Christian Schindlbeck, et al.. (2005). The persistence of isolated tumor cells in bone marrow from patients with breast carcinoma predicts an increased risk for recurrence. Cancer. 103(5). 884–891. 124 indexed citations
5.
Strobl, B., et al.. (2004). Whole body hyperthermia combined with carboplatin/ paclitaxel in patients with ovarian carcinoma –Phase-II-study. Journal of Clinical Oncology. 22(14_suppl). 5128–5128. 2 indexed citations
6.
Rack, Brigitte, W Janni, A. Schoberth, et al.. (2004). Effect of zoledronate on persisting isolated tumor cells (ITC) in the bone marrow (BM) of patients without recurrence of early breast cancer. Journal of Clinical Oncology. 22(14_suppl). 9515–9515. 13 indexed citations
7.
Rack, Brigitte, Wolfgang Janni, Bernd Gerber, et al.. (2003). Patients with Recurrent Breast Cancer: Does the Primary Axillary Lymph node Status Predict more Aggressive Tumor Progression?. Breast Cancer Research and Treatment. 82(2). 83–92. 32 indexed citations
8.
Janni, Wolfgang, Brigitte Rack, Harald Sommer, et al.. (2003). Intra-mammary tumor location does not influence prognosis but influences the prevalence of axillary lymph-node metastases. Journal of Cancer Research and Clinical Oncology. 129(9). 503–510. 20 indexed citations
9.
Janni, Wolfgang, F. Hepp, B. Strobl, et al.. (2003). Patterns of disease recurrence influenced by hematogenous tumor cell dissemination in patients with cervical carcinoma of the uterus. Cancer. 97(2). 405–411. 21 indexed citations
10.
Janni, Wolfgang, H. Sommer, B. Strobl, et al.. (2003). Fortschritte in der Früherkennung des Mammakarzinoms in den Jahren 1981 - 1990. DMW - Deutsche Medizinische Wochenschrift. 128(12). 601–606. 2 indexed citations
11.
Härtl, Kristin, Wolfgang Janni, R Kästner, et al.. (2003). Impact of medical and demographic factors on long-term quality of life and body image of breast cancer patients. Annals of Oncology. 14(7). 1064–1071. 170 indexed citations
12.
13.
Janni, W, B. Strobl, D. Rjosk, et al.. (2003). 426 Intramammary tumor location (ITL) does not influence prognosis, but the prevalence of axillary lymph node metastases. European Journal of Cancer Supplements. 1(5). S129–S130.
14.
Janni, W, et al.. (2002). Der Einfluss des Hämoglobinwertes auf die hämatogene Tumorzelldisseminierung zum Zeitpunkt der Primärdiagnose des Mammakarzinoms. DMW - Deutsche Medizinische Wochenschrift. 127(3). 71–77. 2 indexed citations
15.
Janni, Wolfgang, B Schießl, Ursula Peschers, et al.. (2002). The prognostic impact of a prolonged second stage of labor on maternal and fetal outcome. Acta Obstetricia Et Gynecologica Scandinavica. 81(3). 214–221. 85 indexed citations
16.
Janni, Wolfgang, B Schießl, Ursula Peschers, et al.. (2002). The prognostic impact of a prolonged second stage of labor on maternal and fetal outcome. Acta Obstetricia Et Gynecologica Scandinavica. 81(3). 214–221. 8 indexed citations
17.
18.
Janni, Wolfgang, D. Rjosk, B. Strobl, et al.. (2001). Chemotherapieassoziierte Myelosuppression in der gynäkologischen Onkologie. Gyn�kologisch-geburtshilfliche Rundschau. 41(3). 166–173. 5 indexed citations
19.
Rjosk, D., Th. Dimpfl, B. Strobl, et al.. (2001). Quality of Life Influenced by Primary Surgical Treatment for Stage I-III Breast Cancer?Long-Term Follow-Up of a Matched-Pair Analysis. Annals of Surgical Oncology. 8(6). 542–548. 96 indexed citations
20.
Janni, W, Kristin Härtl, B. Strobl, et al.. (2001). Quality of life influenced by primary surgical treatment for stage I–III breast cancer - long-term follow-up of a matched-pair analysis. European Journal of Cancer. 37. S264–S264. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Philip D. Poorvu Breakdown of academic impact, for papers by Alan C. Winfield Breakdown of academic impact, for papers by J M Howat Breakdown of academic impact, for papers by Margriet van der Heiden‐van der Loo Breakdown of academic impact, for papers by Michael Method Breakdown of academic impact, for papers by İbrahim Vedat Bayoğlu Breakdown of academic impact, for papers by Mustafa Oktay Tarhan Breakdown of academic impact, for papers by Anne Schlesinger‐Raab Breakdown of academic impact, for papers by Bert N. van Geel Breakdown of academic impact, for papers by Magali Verheecke
Rankless by CCL
2026